Clinical Trials Browser

OTHER × Lymphoma × orelabrutinib × Clear all

NCT07206264 2025-10-03

ADAPT-MCL

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Mantle-Cell

NCT06015464 2023-08-29

An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL

Lymphoma